According to the company, discontinuing use does not cause adverse effects, though the body may gradually return to its baseline
For example, in the treatment of Alzheimers diseases (AD) and Parkinsons diseases (PD), GLP-1RAs have shown potential in slowing disease progression, while their anti-inflammatory properties offer new hope for conditions such as osteoarthritis (OA), rheumatoid arthritis (RA) and cardiovascular diseases
GLP-1 receptor agonists work by mimicking the naturally occurring incretin hormone GLP-1, which enhances glucose-dependent insulin secretion, suppresses glucagon release, and slows gastric emptying
Editors Note: Following a May 2026 global consensus, polycystic ovary syndrome (PCOS) is now officially called polyendocrine metabolic ovarian syndrome (PMOS), highlighting the metabolic roots of the condition
For some, the time spent on GLP-1s has supported a change in habits and lifestyle that can help them maintain their weight loss on a low dose. GLP-1 Microdosing vs
The receptors do not care whether you took the dose on time or early